|
|
Influence of Exenatide on homocysteine-induced injury in human umbilical vein endothelial cells |
DENG Guo-xiong WEI Jin-ru▲ CHEN Mei-xiang |
Department of Cardiology,the First People′s Hospital of Nanning City,Guangxi Zhuang Autonomous Region,Nanning 530022,China |
|
|
Abstract Objective To explore the influence of Exenatide on homocysteine (Hcy)-induced injury in human umbilical vein endothelial cells (HUVECs).Methods Hcy-induced HUVECs were used to establish an inflammatory injury model,which were divided into the normal group,the model group (200 μmol/L Hcy),the low dose of Exenatide treatment group (200 μmol/L Hcy,ExE-L 5 nmol/L),the medium dose of Exenatide treatment group (200 μmol/L Hcy,ExE-M 10 nmol/L),the high dose of Exenatide treatment group(200 μmol/L Hcy,ExE-H 20 nmol/L).The cell viability in each group was detected,and the content of nitric oxide(NO),the level of interleukin-6(IL-6),the level of intercellular adhesion factor-1(ICAM-1),the level of endothelin-1(ET-1),the expression of inhibitor protein kappa B-alpha(IκBα)and nuclear factor-κB (NF-κB)p65 protein were compared.Results The cell viability,the content of NO and protein expression of IκBα in the model group were significantly lower than that in the control group,the supernatant levels of IL-6,ICAM-1 and ET-1 and protein expression of NF-κB p65 in the model group were significantly higher than those in the control group,with significant difference (P<0.05).The cell viability,the content of NO and protein expression of IκBα in the each Exenatide group were significantly lower than those in the model group,the supernatant levels of IL-6,ICAM-1,ET-1 and the protein expression of NF-κB p65 in the each Exenatide group were significantly lower than those in the model group,with significant difference(P<0.05).Conclusion Exenatide can improve Hcy-induced HUVECs,injuried through inhibiting inflammatory response.
|
|
|
|
|
[1] |
吴月姣,刘元飞,雷琦.高同型半胱氨酸血症与相关疾病关系的研究进展[J].中国实用神经疾病杂志,2018,21(11):1161-1165.
|
[2] |
Boyi Y,Shu JF,Xue YZ,et al.Prevalence of hyperhomocysteinemia in China:a systematic review and meta-analysis[J].Nutrients,2014,7(1):74-90.
|
[3] |
刘湘茹,李玥,杨斌,等.2型糖尿病患者血浆同型半胱氨酸水平及相关因素分析[J].中国当代医药,2018,25(14):57-59.
|
[4] |
陈亮,杨华章,江桂芬,等.糖尿病患者血同型半胱氨酸分布特点及相关因素分析[J].广东医学,2007,28(12):1954-1955.
|
[5] |
王晓昊,韩丽娜,余叶蓉,等.GLP-1类似物exenatide对糖尿病患者心脏舒张功能及内皮依赖性血管舒张的影响[J].四川大学学报(医学版),2015,46(4):586-590.
|
[6] |
蒋建家,牟伦盼,林振忠,等.艾塞那肽对糖调节受损肥胖者血胰岛素及胰岛素抵抗的影响[J].中国糖尿病杂志,2013,5(8):481-485.
|
[7] |
Ridker PM,Everett BM,Thuren T,et al.Antiinflammatory therapy with canakinumab for atherosclerotic disease[J].N Engl J Med,2017,377(12):1119-1131.
|
[8] |
徐志红,陆国平,吴春芳.高同型半胱氨酸血症对内皮细胞炎症反应的促发作用及其干预性研究[J].中国动脉硬化杂志,2007,30(5):353-357.
|
[9] |
李颖,毛瑞阳,杜晓红,等.天麻素对同型半胱氨酸诱导的细胞因子表达的影响[J].中华中医药学刊,2014,32(2):393-395.
|
[10] |
Wang R,Wang Y,Mu N,et al.Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice[J].Lab Invest,2017,97(8):922-934.
|
[11] |
陈丽远,王钢.同型半胱氨酸水平与冠心病关系的研究进展[J].中国心血管杂志,2017,22(4):304-307.
|
[12] |
李军,王国荣,王燕,等.二苯乙烯苷对同型半胱氨酸诱导的人脐静脉内皮细胞MCP-1、ICAM-1和VCAM-1表达的影响[J].中国动脉硬化杂志,2012,20(10):890-894.
|
[13] |
林丽艳,张慧云,何韶衡.IL-6及其受体与炎症性疾病关系的新进展[J].中国热带医学,2008,8(4):680-682.
|
[14] |
邹福兰,骆娟,黄蓉,等.IκBα 在 NF-κB 信号通路中的作用及临床意义[J].中华临床医师杂志(电子版),2014,8(3):138-141.
|
[15] |
刘开泰,韩秀敏,张阳.IκB激酶结构和功能研究进展[J].大连医科大学学报,2007,29(1):85-88.
|
[16] |
柳学,李志莲,何楷然,等.动态观察强化胰岛素与常规胰岛素治疗对高血糖重症患者血清TNF-α、IL-1β、IL-6、IL-10变化及预后的影响[J].广州医科大学学报,2016,44(3):5-10.
|
[17] |
高梅.内皮素和一氧化氮检测对糖尿病血管内皮功能的评价作用[J].齐齐哈尔医学院学报,2015,36(29):4422-4423.
|
[18] |
丁波,张倩,吴锦丹,等.胱抑素C及同型半胱氨酸的血清含量与糖尿病肾病患者肾小球滤过率的相关性研究[J].实用医学杂志,2012,28(8):1268-1270.
|
|
|
|